Literature DB >> 31925468

Tumor T2 signal intensity and stalk angulation correlates with endocrine status in pituitary adenoma patients: a quantitative 7 tesla MRI study.

John W Rutland1,2, Puneet Pawha3, Puneet Belani3, Bradley N Delman4,3, Corey M Gill5, Teresa Brown6, Khadeen Cheesman6, Raj K Shrivastava5, Priti Balchandani4.   

Abstract

PURPOSE: Pituitary adenomas are common CNS tumors that can cause endocrine dysfunction due to hormone oversecretion and by mass effect on the normal gland. The study of pituitary adenomas and adjacent sellar anatomy with high-resolution 7 T MRI may further characterize endocrine dysfunction. The purpose of this study was to determine the efficacy of 7 T MRI in identifying radiological markers for endocrine function.
METHODS: MR images obtained in 23 patients with pituitary adenomas were reviewed by consensus between three neuroradiologists. Landmarks and criteria were devised to measure radiological features of stalk, tumor, and normal gland. Fischer's exact tests and nominal logistic regression were performed.
RESULTS: Mean cross-sectional area of the stalk just below the infundibular recess was 6.3 ± 3.7 mm2. Mean curvature and deviation angles were 34.2° ± 23.2° and 29.7° ± 17.3°, respectively. Knosp scores obtained differed between 7 T and lower field strength scans (P < 0.0001 [right] and P = 0.0006 [left]). Ability to characterize tumor was rated higher at 7 T compared with lower field MRI, P = 0.05. Confidence in visualizing normal gland was also higher using 7 T MRI, P = 0.036. The six hormone-secreting tumors had higher corrected T2 mean SI than non-secreting tumors (2.54 vs. - 0.38, P = 0.0196). Seven patients had preoperative hypopituitarism and had significantly greater stalk curvature angles than patients without hypopituitarism (71.7° vs. 36.55°, P = 0.027).
CONCLUSION: Radiological characterization of pituitary adenomas and adjacent native pituitary tissue may benefit with the use of 7 T MRI. Corrected T2 SI of tumor may be a sensitive predictor of hormonal secretion and may be useful in the diagnostic work-up for pituitary adenoma. 7 T MRI may be valuable in identifying markers of endocrine function in patients with pituitary adenomas. Our results indicate that hormone-secreting tumors have higher T2-weighted SI and tumors associated with preoperative hypopituitarism have greater stalk curvature angles.

Entities:  

Keywords:  Endocrine abnormality; Pituitary adenoma; Pituitary infundibulum; Ultrahigh field MRI

Year:  2020        PMID: 31925468      PMCID: PMC7205143          DOI: 10.1007/s00234-019-02352-4

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  30 in total

1.  Trading off SNR and resolution in MR images.

Authors:  Shoan C Kale; X Josette Chen; R Mark Henkelman
Journal:  NMR Biomed       Date:  2009-06       Impact factor: 4.044

Review 2.  Medical management of hypopituitarism in patients with pituitary adenomas.

Authors:  Baha M Arafah
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

3.  Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading.

Authors:  Michael A Mooney; Douglas A Hardesty; John P Sheehy; Robert Bird; Kristina Chapple; William L White; Andrew S Little
Journal:  J Neurosurg       Date:  2016-07-01       Impact factor: 5.115

4.  Correlation of high signal intensity of the pituitary stalk in macroadenoma and postoperative diabetes insipidus.

Authors:  Naokatsu Saeki; Seiichiro Hoshi; Souichi Sunada; Kenro Sunami; Hisayuki Murai; Motoo Kubota; Ichiro Tatsuno; Toshihiko Iuchi; Akira Yamaura
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

5.  CT of the normal pituitary stalk.

Authors:  R G Peyster; E D Hoover; L P Adler
Journal:  AJNR Am J Neuroradiol       Date:  1984 Jan-Feb       Impact factor: 3.825

6.  The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas.

Authors:  B M Arafah; D Prunty; J Ybarra; M L Hlavin; W R Selman
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.

Authors:  M V Smith; E R Laws
Journal:  Neurosurgery       Date:  1994-05       Impact factor: 4.654

8.  Cavernous sinus invasion by pituitary adenomas.

Authors:  J Ahmadi; C M North; H D Segall; C S Zee; M H Weiss
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

9.  Transsphenoidal surgery of parasellar pituitary adenomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

10.  Pituitary stalk interruption syndrome: Case report of three cases with review of literature.

Authors:  Manish Gutch; Sukriti Kumar; Syed Mohd Razi; Sanjay Saran; Keshav Kumar Gupta
Journal:  J Pediatr Neurosci       Date:  2014-05
View more
  4 in total

1.  Novel Nomograms to Predict Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma.

Authors:  Kunzhe Lin; Ran Zeng; Shuwen Mu; Yinghong Lin; Shousen Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma.

Authors:  Kunzhe Lin; Kaichun Fan; Shuwen Mu; Shousen Wang
Journal:  Eur J Med Res       Date:  2022-05-25       Impact factor: 4.981

3.  Risk factors for delayed postoperative hyponatremia in patients with non-functioning pituitary adenomas undergoing transsphenoidal surgery: A single-institution study.

Authors:  Yinxing Huang; Meina Wang; Jianwu Wu; Kunzhe Lin; Shousen Wang; Fangfang Zhang
Journal:  Front Neurol       Date:  2022-07-19       Impact factor: 4.086

4.  Diaphragma sellae sinking can predict the onset of hyponatremia after transsphenoidal surgery for pituitary adenomas.

Authors:  Kunzhe Lin; Jun Li; Lingling Lu; Shangming Zhang; Shuwen Mu; Zhijie Pei; Cheng Wang; Jingying Lin; Liang Xue; Liangfeng Wei; Lin Zhao; Shousen Wang
Journal:  J Endocrinol Invest       Date:  2021-06-14       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.